CompletedNCT00377949
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Studying Diffuse cutaneous systemic sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Georgetown University
- Principal Investigator
- Virginia D. Steen, MDGeorgetown University
- Enrollment
- 602 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2005
Study locations (25)
- UCLA Medical Center, Los Angeles, California, United States
- Stanford University, Stanford, California, United States
- National Jewish Medical and Research Center, Denver, Colorado, United States
- Georgetown University Medical Center, Washington D.C., District of Columbia, United States
- Northwestern University, Chicago, Illinois, United States
- University of Chicago, Chicago, Illinois, United States
- Louisiana State University Health Science Center, New Orleans, Louisiana, United States
- John Hopkins University Medical Center, Baltimore, Maryland, United States
- Tufts Medical Center, Boston, Massachusetts, United States
- Boston University Medical School, Boston, Massachusetts, United States
- University of Massachussetts Memorial Medical Center, Worcester, Massachusetts, United States
- University of Michigan-Scleroderma Program, Ann Arbor, Michigan, United States
- Hennepin County Medical Center, Minneapolis, Minnesota, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, United States
- +10 more locations on ClinicalTrials.gov
Collaborators
Gilead Sciences
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00377949 on ClinicalTrials.govOther trials for Diffuse cutaneous systemic sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07473154Controlling Hyperactive Immunity With Long-lived LymphocytesQuell Therapeutics Limited
- RECRUITINGPHASE1, PHASE2NCT06947473Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.Beijing GoBroad Hospital
- RECRUITINGPHASE2NCT05029336Autologous Stem Cell Transplant (ASCT) for Autoimmune DiseasesStephan Grupp MD PhD
- RECRUITINGPHASE2NCT07047690A Study of Nemolizumab for the Treatment of Adults With Systemic SclerosisGalderma R&D
- RECRUITINGPHASE2NCT07287670EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)Mediar Therapeutics
- RECRUITINGNCT07256418Transcriptomic Study of Cutaneous Fibroblasts in SclerodermaCentre Hospitalier Universitaire Dijon
- RECRUITINGPHASE1NCT07295847A Study of AZD0120 in Autoimmune DiseasesAstraZeneca
- RECRUITINGNANCT07292961Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With SclerodermaHacettepe University